Tuberculosis among European patients with the acquired immune deficiency syndrome

Tubercle and Lung Disease

Volumn 77, Issue 4, 1996, Pages 322-328

  Sudre, P ^a,k   Hirschel, B J ^a   Gatell, J M ^b   Schwander, S ^c   Vella, S ^d   Katlama, C ^e   Ledergerber, B ^f   D'Arminio Monforte, A ^g   Goebel, F D ^h   Pehrson, P O ⁱ   Pedersen, C ^j   Lundgren, J D ^j  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b HOSPITAL CLÍNIC   (Spain)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^d Instituto Superiore   (Italy)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f Swiss HIV Cohort Study   (Switzerland)

^g UNIVERSITY OF MILAN   (Italy)

^h UNIVERSITY OF MUNICH   (Germany)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

^k HCUG   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; COMPARATIVE STUDY; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; RISK FACTOR; SEX DIFFERENCE; SURVIVAL; TUBERCULOSIS; VIRUS TRANSMISSION;

EID: 15844367455     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8479(96)90096-9     Document Type: Article

References (26)

1. Horsburgh C R Jr, Pozniak A. Epidemiology of tuberculosis in the era of HIV. AIDS 1993; 7 Suppl 1: S109-14.
2. Dolin P J, Raviglione M C, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994; 72: 213-220.
3. Sudre P, ten Dam G, Kochi A Tuberculosis: a global overview of the situation today. Bull World Health Organ 1992; 70: 149-159
4. Guelar A, Gatell J M, Verdejo J et al. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 1993; 7: 1345-1349
5. Tuberculose et V.I.H. en France. B E H 1993; 15: 63-67.
6. van Deutekom H, Warris Versteegen A A, Krijnen P et al. The HIV epidemic and its effect on the tuberculosis situation in The Netherlands. Tubercle Lung Dis 1993; 74: 159-162
7. La tuberculose en Suisse: 1988-1992. Bulletin de l'Office fédéral de la santé publique 1993; 15: 739-745,
8. Raviglione M C, Sudre P, Rieder H L, Spinaci S, Kochi A. Secular trends of tuberculosis in western Europe. Bull World Health Organ 1993; 71: 297-306.
9. Lundgren J D, Pedersen C, Clumeck N et al. Survival differences in European patients with AIDS, 1979-1989. The AIDS in Europe Study Group. BMJ 1994; 308: 1068-1073.
10. Revision of the CDC case definition for acquired immunodeficiency syndrome. MMWR 1987: 36: 3-15.
11. Barnes P F, Bloch A B, Davidson P T, Snider D E. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324: 1644-1650.
12. Slutsker L, Castro K G, Ward J W, Dooley S W. Epidemiology of extrapulmonary tuberculosis among persons with AIDS in the United States. Clin Infect Dis 1993; 16: 513-518.
13. Bouza E, Martin-Scapa C, Bernaldos-de-Quiros J et al. High prevalence of tuberculosis in AIDS patients in Spain. Eur J Clin Microbiol Infect Dis 1988; 7: 185-188.
14. Styblo K. The relationship between the risk of tuberculous infection and the risk of developing infectious tuberculosis. Bull Int Union Tuberc 1985; 60: 117-119
15. Murray C J, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990; 65: 6-24.
16. Selwyn P A, Hartel D, Lewis V A et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545-550.
17. Braun M M, Badi N, Ryder R W et al. A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire. Am Rev Respir Dis 1991; 143: 501-504.
18. Girardi E, Antonnucci G, Ippolito G, Armignacco O, GISTA. Prospective evaluation of risk of tuberculosis in HIV-infected persons by tuberculin reaction size. Tenth International Conference on AIDS, Yokohama, Japan 1994; Abstract No. 405B: 28).
19. Moreno S, Baraia Etxaburu J, Bouza E et al. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993; 119: 194-198.
20. Sudre P, Hirschel B, Toscani L, Ledergerber B, Rieder H L, and the Swiss HIV Cohort Study. Risk factors for tuberculosis among HIV-infected patients in Switzerland. Eur Resp J 1996; 19: In press.
21. Braun M M, Byers R H, Heyward W L et al. Acquired immunodeficiency syndrome and extrapulmonary tuberculosis in the United States. Arch Intern Med 1990; 150: 1913-1916
22. Alland D, Kalkut G E, Moss A R et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330: 1710-1716.
23. Small P M, Schecter G F, Goodman P C, Sande M A, Chaisson R E, Hopewell P C. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 1991; 324: 289-294.
24. Whalen C, Horsburgh C R, Horn D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995; 151: 129-135.
25. Perneger T V, Sudre P, Lundgren J D, Hirschel B, for the AIDS in Europe Study Group. Does the onset of tuberculosis in AIDS patients predict shorter survival? Results of a cohort study in 17 European countries over 13 years. BMJ 1995; 311: 1468-1471
26. Angarano G, Carbonara S, Costa D. Tuberculosis susceptibility to first-line drugs in HIV+ population: An Italian Multicentric observational study. Fifth European Conference on Clinical Aspects and Treatment of HIV Infection. Copenhagen, 26-29 Septembre 1995. Abstract No. 2.